---
title: "SAB Biotherapeutics (SABS.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/SABS.US/norm.md"
symbol: "SABS.US"
name: "SAB Biotherapeutics"
parent: "https://longbridge.com/zh-HK/quote/SABS.US.md"
datetime: "2026-03-08T08:15:16.069Z"
locales:
  - [en](https://longbridge.com/en/quote/SABS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SABS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SABS.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/SABS.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/SABS.US/norm.md)


# SAB Biotherapeutics (SABS.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2126 | 0.7491 | -0.5593 | -1.23 | -1.12 |
| ROE | 24.11% | 166.73% | -87.75% | -144.99% | -99.73% |
| 營業收入 | - | - | - | 114698.00 | - |
| 凈利潤 | 5.34M | 6.97M | -5.20M | -11.39M | -10.35M |
| 營業利潤 | -12.68M | -9.73M | -10.77M | -10.01M | -11.31M |
| 毛利率 | - | - | - | -6571.14% | - |
| 凈利率 | - | - | - | -9934.52% | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 183.45M | 30.13M | 38.12M | 44.20M | 53.80M |
| 權益乘數 | 1.11 | 2.51 | 1.78 | 1.70 | 1.46 |
| 每股凈資產 | 3.48 | 1.29 | 2.30 | 2.80 | 4.00 |
| 資產周轉率 | 0.0010 | 0.0025 | 0.0069 | 0.0206 | 0.0368 |
| 現金及短投 | 110.88M | 5.71M | 12.85M | 20.76M | 30.40M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 19.44M | 20.40M | 21.37M | 19.92M | 20.75M |
| 凈債務 | -104.69M | 705092.00 | -6.07M | -16.09M | -25.88M |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -13.05M | -7.15M | -7.80M | -9.53M | -6.29M |
| 投資現金流 | -129.87M | 5.20M | 4.67M | 9.33M | -1.15M |
| 融資現金流 | 168.69M | -173844.00 | -173985.00 | 216961.00 | -674130.00 |
| 自由現金流 | -5.07M | -3.69M | -4.35M | -6.87M | -3.08M |
| 現金流充裕率 | -36270.21% | -4113.77% | -4535.56% | -2893.21% | -839.58% |
| 舉債與償債 | - | - | - | 515986.00 | - |
| 資本支出 | - | - | - | -55377.00 | -100300.00 |